• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
SNT 12.5% 1.8¢

SYNTARA LIMITED

Syntara Limited, formerly Pharmaxis Ltd, is an Australia-based clinical-stage drug... Syntara Limited, formerly Pharmaxis Ltd, is an Australia-based clinical-stage drug development company with a focus on blood-related cancers. The Company’s highly productive drug discovery engine is driven by its expertise in amine oxidase inhibitors. Its lead candidate, PXS-5505, is used for the bone marrow cancer myelofibrosis, which causes a build-up of scar tissue that leads to loss of red and white blood cells and platelets. The Company is also advancing both oral and topical pan-LOX inhibitors in scar prevention and scar modification programs. Its PXS-4728 is a SSAO/MAOB inhibitor to treat sleep disorders and slow progression of neurodegenerative diseases like Parkinson’s by reducing neuroinflammation. The Company’s other drug candidates target fibrotic and inflammatory diseases such as kidney fibrosis, NASH, pulmonary fibrosis, and cardiac fibrosis. It has developed two respiratory products: Bronchitol, for cystic fibrosis, and Aridol, a lung function test.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
SNT 10/05/24 13 2.5K
10/05/24 Last post  ContangoPhil Comments Created with Sketch.  13  Views Created with Sketch.  2.5K 
SNT 30/04/24 0 108
30/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  108 
SNT 30/04/24 0 153
Metals & Mining SECTOR NEWS

Alara Resources is driving Oman into a renewable renaissance with accelerating copper production

AUQ
10 May 2024
ALARA RESOURCES LIMITED
30/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  153 
SNT 30/04/24 0 99
30/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  99 
SNT 30/04/24 0 117
30/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  117 
SNT 29/04/24 0 139
29/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  139 
SNT 28/04/24 13 3.3K
28/04/24 Last post  ContangoPhil Comments Created with Sketch.  13  Views Created with Sketch.  3.3K 
SNT 24/04/24 0 181
24/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  181 

See All Discussions arrow Created with Sketch.

Timeline

Application for quotation of securities - SNT
30 Apr 14:54
 
Updated company investor presentation
30 Apr 11:36
 
Presentation for quarterly shareholder briefing
30 Apr 10:38
 
Quarterly Activities Report
30 Apr 08:45
 
Quarterly Activities/Appendix 4C Cash Flow Report
30 Apr 08:44
 
Notification of cessation of securities - SNT
29 Apr 17:22
 
View More arrow Created with Sketch.
(20min delay)
Last
1.8¢
Change
0.002(12.5%)
Mkt cap ! $21.49M
Open High Low Value Volume
1.6¢ 1.8¢ 1.6¢ $4.982K 285.1K

Buyers (Bids)

No. Vol. Price($)
3 1700000 1.6¢
 

Sellers (Offers)

Price($) Vol. No.
1.8¢ 2865310 5
View Market Depth
Last trade - 16.10pm 10/05/2024 (20 minute delay) ?
Last
1.8¢
  Change
0.002 ( 12.5 %)
Open High Low Volume
1.6¢ 1.8¢ 1.6¢ 316806
Last updated 15.26pm 10/05/2024 ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.